The National Institute on Drug Abuse (NIDA) awarded Tenvos Inc., a minority-owned and woman-owned business, a $800,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a software-based medical device for detecting opioid use through voice analysis. The proposed solution will integrate into a smartphone app, enabling patients to conduct opioid use tests from home and securely transmit results to clinicians, eliminating the need for in-person visits. This aims to improve clinical outcomes and treatment retention rates for individuals with opioid use disorder by increasing accessibility and convenience of monitoring. The project includes data collection, model validation, and engagement with the FDA to determine the appropriate regulatory pathway. Additionally, a sub-award was provided to support patient enrollment and recruitment for the project protocol.
Generated 3/4/25, 7:43 AM